SCHEMBL2910370

SCHEMBL2910370

Cc1[nH]c2ccc(F)cc2c1C(c1ccc[nH]1)S(=O)(=O)c1ccc(Cl)cc1Cl

nearest known ligand 0.34

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LGALS8 O00214 2/20 0.34
CCR2 P41597 1/20 0.33
KDM4E B2RXH2 2/20 0.33
PTGDR2 Q9Y5Y4 1/20 0.33
NR3C1 P04150 2/20 0.32
NR3C2 P08235 1/20 0.32
LMNA P02545 2/20 0.32
MEN1 O00255 2/20 0.32
KMT2A Q03164 2/20 0.32
PKM P14618 1/20 0.32
MAPK1 P28482 1/20 0.32
SMN1; SMN2 Q16637 1/20 0.32
ALDH1A1 P00352 2/20 0.32
THRB P10828 1/20 0.32
KIF11 P52732 1/20 0.32
GLA P06280 1/20 0.32
GAA P10253 1/20 0.32
HTT P42858 1/20 0.32
KEAP1 Q14145 1/20 0.32
NFE2L2 Q16236 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1783342 0.78 PTGDR2 (0.51) PTGDR2
SCHEMBL2539312 0.64 PTGDR2 (0.47) PTGDR2
SCHEMBL23502011 0.63 KIF11 (0.53) KDM4ELMNAMEN1KMT2ASMN1; SMN2
SCHEMBL15873533 0.62 ACHE (0.55) KDM4ELMNAMEN1KMT2AMAPK1
SCHEMBL25498024 0.60 SIRT1 (0.55) LMNAMEN1KMT2AALDH1A1GAA
SCHEMBL713777 0.60 HDAC8 (0.44) KDM4ENR3C1NR3C2MEN1KMT2A
SCHEMBL11827114 0.59 KIF11 (0.45) KDM4ELMNAMEN1KMT2ASMN1; SMN2
SCHEMBL13797487 0.59 AKR1B1 (0.44) CCR2PKMALDH1A1PTGS2TRPV4
SCHEMBL26511201 0.59 KIF11 (0.64) KDM4ELMNAMEN1KMT2AMAPK1
SCHEMBL6004999 0.59 PTGDR2 (0.39) KDM4EPTGDR2LMNASMN1; SMN2ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2219645-A2 USE OF CRTH2 ANTAGONIST COMPOUNDS Oxagen Limited (GB) 2010-08-25 EP claimed
WO-2009063215-A2 USE OF CRTH2 ANTAGONIST COMPOUNDS OXAGEN LIMITED (GB) 2009-05-22 WO claimed
WO-2009063202-A2 USE OF CRTH2 ANTAGONIST COMPOUNDS OXAGEN LIMITED (GB) 2009-05-22 WO claimed
EP-2219645-A2 USE OF CRTH2 ANTAGONIST COMPOUNDS Oxagen Limited (GB) 2010-08-25 EP disclosed
WO-2009063202-A2 USE OF CRTH2 ANTAGONIST COMPOUNDS OXAGEN LIMITED (GB) 2009-05-22 WO disclosed